Thompson v. Orkin, LLC

District Court, E.D. Michigan·Decided February 24, 2025·No. 1:20-cv-13085·Unknown

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION 1:20-CV-13085-TGB-PTM ARDIS THOMPSON and HON. TERRENCE G. BERG GLORIA THOMPSON, OPINION AND ORDER Plaintiffs, GRANTING IN PART AND v. DENYING IN PART DEFENDANT’S MOTION FOR SUMMARY JUDGMENT ORKIN, LLC, (ECF NO. 51) Defendant.

In this toxic tort case, Plaintiffs Ardis Thompson and Gloria Thompson allege that Defendant Orkin, LLC negligently over-applied a pesticide to their home on two occasions, causing the Thompsons to suffer physical and emotional injuries as well as economic damages. Now before the Court is Defendant’s Motion for Summary Judgment, ECF No. 51, seeking summary judgment on the Thompsons’ claims. The motion is fully briefed, and the Court will consider the motion without oral argument pursuant to E.D. Mich. LR 7(f)(2). After careful consideration of the parties’ briefing, the Court will GRANT IN PART and DENY IN PART Defendant’s Motion for Summary Judgment for the reasons stated below. I. BAKGROUND

A. Factual Background In May 2018, Plaintiffs Gloria and Ardis Thompson contacted Defendant Orkin, LLC to treat their home for insects because Mrs. Thompson was experiencing “itching” which she attributed to bug bites. G. Thompson Dep. 55–56, 80–81, ECF No. 44-8, PageID.632, 638. On May 31, 2018, Orkin technician Paul Hutchinson treated the Thompsons’ bedroom for fleas using PT Alpine Flea and Bug Pressurized Insecticide (“PT Alpine”), manufactured by BASF. ECF No. 44-6, PageID.577.

PT Alpine is a “non-restricted use” pesticide, meaning it is registered with the Environmental Protection Agency (“EPA”), the EPA has reviewed and approved it for general use by consumers, and that no special license or training is necessary to use it. Christopher Weis Dep. 25, ECF No. 44-4, PageID.504. The PT Alpine label states that it “Kills fleas for up to 30 days. Kills hatching flea eggs for up to 7 months…. FOR USE IN: Apartments, Commercial Structures, Homes, Hotels, Kennels, Motels, and Veterinary Clinics.” ECF No. 44-2, PageID.454. The label provides that it should be applied “at the rate of 20 ounces [one can] for

up to 2,625 square feet (10 ounces [half can] for up to 1,300 square feet), applying in a sweeping motion at a speed of 1 foot per second. DO NOT apply more than 20 ounces per 2,625 square feet.” Id. PageID.456. The directions further state that users must “[v]acate areas to be treated and DO NOT reoccupy or contact treated surfaces until dry.” Id. The “Precautionary Statements” section of the PT Alpine label, the

subsection labelled “Hazards to Humans and Domestic Animals,” provides: CAUTION. Contains Petroleum Distillate. Avoid contact with skin or clothing. Wash thoroughly with soap and water after handling and before eating, drinking, chewing gum, using tobacco, or using the toilet. Id. PageID.455. The “First Aid” section of the label further provides that if PT Alpine comes in contact with the skin to (1) “[t]ake off contaminated clothing” (2) “[r]inse skin immediately with plenty of water for 15 to 20 minutes” and (3) “[c]all a poison control center or doctor for treatment or advice.” Id. At the Thompsons’ regular pest control visit on June 28, 2018, Mrs. Thompson informed Orkin employee Mike Baker that she was still experiencing what she believed to be insect bites. G. Thompson Dep. 55– 56, 80–81, ECF No. 44-8, PageID.632, 638. In response, Baker applied a second PT Alpine flea treatment to the Thompsons’ house on July 18, 2018. Id. 113, PageID.646; ECF No. 44-9, PageID.696. The service ticket for that second application states that the Orkin technician “treated all the carpeted rooms and tiled kitchen and bathrooms” and lists the

following locations: bathroom, bedroom, kitchen, living room. ECF No. 44-9, PageID.696. Baker instructed the Thompsons to leave the house for at least four hours following the treatment, G. Thompson Dep. 80–81, ECF No. 44-8, PageID.638, and the Thompsons testified that they did not return to their home for over eight hours. Id. 78; A. Thompson Dep. 67–

68, ECF No. 44-12, PageID.784. Upon returning to the house that evening, the Thompsons state that the carpeting on the floor in the house was still damp to the touch. G. Thompson Dep. 75, ECF No. 44-8, PageID.637; A. Thompson Dep. 28, ECF No. 44-12, PageID.774. Mrs. Thompson testified that she walked on the carpet barefoot and afterwards felt a “burning” sensation that “starts from the inside out,” extending “[a]ll over [her] body.” G. Thompson Dep. 47, 58, 70–71, ECF No. 44-8, PageID.630, 633, 636. That evening, Mrs.

Thompson bathed with water because of the burning sensation, and Mr. Thompson took a shower. Id. 117, PageID.647. Mr. Thompson testified that a couple of days after their home was treated with PT Alpine for the second time, he “started feeling this burning in my feet” which led to “numbness” and “tingling” in his feet. A. Thompson Dep. 28–29, ECF No. 44-12, PageID.774. Approximately three weeks later, on August 9, 2018, Mrs. Thompson went to the Covenant Hospital Emergency Department reporting a “burning sensation to her entire body.” ECF No. 44-11,

PageID.730. The emergency room records document that Mrs. Thompson has a history of anxiety and rheumatoid arthritis and that upon examination she had no rash or skin color change. Id. PageID.731–32. The doctor noted that Mrs. Thompson complained that she had been exposed to PT Alpine several weeks ago when her home was treated for fleas, and he noted that he “highly doubt[ed] that an exposure several

weeks ago would be causing [Mrs. Thompson’s] symptoms.” Id. The doctor further noted that he “did speak with poison Control” and that “[t]hey believe this exposure is less likely to be causing the patient’s symptoms.” Id. PageID.730–32. The doctor however advised Mrs. Thompson “to have her carpets washed as continued exposure may be causing her symptoms” and diagnosed Mrs. Thompson with “[d]iffuse pain” and “[d]ermal chemical exposure.” Id. PageID.732. Mr. Thompson claims that while he felt “numbness,” “tingling,” and

“burning” in his feet a couple of days after the July 18, 2018 PT Alpine treatment, he did not seek medical treatment for these symptoms at that time. A. Thompson Dep. 28–29, 32–33, ECF No. 44-12, PageID.774–75. Mr. Thompson testified that he did, however, talk to his regular doctor about “the situation that was happening” approximately six months later, in January 2019 during his Medicare annual wellness visit. Id. 131–132, PageID.800. At that visit, Mr. Thompson testified that he reported “[a] little itching” on his face and a burning feeling in his feet. Id. 134–135, PageID.801.

On November 29, 2018, the Thompsons filed a complaint with the Michigan Department of Agriculture and Rural Development (“MDARD”) against Orkin concerning the two PT Alpine applications in their home. MDARD Inspection Report, ECF No. 44-13, PageID.820. MDARD investigated the Thompsons’ complaint and on December 3, 2018, collected five swab samples (with one of those swabs being a “blank”

sample, meaning it did not “swab” a surface in the Thompsons’ home and was used to test for any contamination or ambient sources of the chemicals tested for), 1 clothing sample, and 1 carpet sample at the Thompsons’ home and tested these samples for the presence of the three active ingredients in PT Alpine: dinotefuran, pyriproxyfen, and prallethrin. Id. at PageID.826. Each of the non-blank test samples contained trace amounts of dinotefuran and pyriproxyfen, and only one test sample contained trace amounts of prallethrin. Id. PageID.820, 826.

MDARD concluded that “[s]ample results show that trace amounts of the active ingredients in PT Alpine [ ] in the [Thompsons’] home while application records indicate the product was slightly over applied during the May 31st, 2018 application to the [Thompsons’] home.” Id. PageID.820.

Free access — add to your briefcase to read the full text and ask questions with AI

Thompson v. Orkin, LLC, (E.D. Mich. 2025).

Thompson v. Orkin, LLC (Thompson v. Orkin, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Erie Railroad v. Tompkins
304 U.S. 64 (Supreme Court, 1938)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
O’neal v. St John Hospital & Medical Center
791 N.W.2d 853 (Michigan Supreme Court, 2010)
Lash v. City of Traverse City
735 N.W.2d 628 (Michigan Supreme Court, 2007)
Henry v. Dow Chemical Company
701 N.W.2d 684 (Michigan Supreme Court, 2005)
Sherry Trost v. Zachary Trost
525 F. App'x 335 (Sixth Circuit, 2013)
Alexander v. CareSource
576 F.3d 551 (Sixth Circuit, 2009)
Best v. Lowe's Home Centers, Inc.
563 F.3d 171 (Sixth Circuit, 2009)
Candelaria v. B C General Contractors, Inc
600 N.W.2d 348 (Michigan Court of Appeals, 1999)
Gass v. Marriott Hotel Services, Inc.
558 F.3d 419 (Sixth Circuit, 2009)
Genna v. Jackson
781 N.W.2d 124 (Michigan Court of Appeals, 2009)
Bernhardt v. Ingham Regional Medical Center
641 N.W.2d 868 (Michigan Court of Appeals, 2002)
Skinner v. Square D Co.
516 N.W.2d 475 (Michigan Supreme Court, 1994)
Weymers v. Khera
563 N.W.2d 647 (Michigan Supreme Court, 1997)
Strzelecki v. Blaser’s Lakeside Industries of Rice Lake, Inc
348 N.W.2d 311 (Michigan Court of Appeals, 1984)
Willis v. Ed Hudson Towing, Inc
311 N.W.2d 776 (Michigan Court of Appeals, 1981)
Johnson v. Bobbie's Party Store
473 N.W.2d 796 (Michigan Court of Appeals, 1991)
Beckie Price v. High Pointe Oil Co Inc
828 N.W.2d 660 (Michigan Supreme Court, 2013)